Navigation Links
Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority
Date:6/18/2013

Phoenix, AZ (PRWEB) June 18, 2013

Nasseo, Inc. today announces that it has been named the 2013 Innovation Challenge Winner out of hundreds of applicants by the Arizona Commerce Authority (ACA) in its spring Arizona Innovation Challenge. The Arizona Innovation Challenge (AIC) awards the most money in the country for a technology commercialization challenge, granting a financial award to what it deems to be the world’s most promising technology ventures. Nasseo’s state of the art dental and orthopedic implant surface modification technology captured the attention of the ACA this year. With this victory, Nasseo is honored to accept a $250,000 grant award to commercialize their first product, the TiArray™ Dental Implant.

In the ACA’s press release about the award, Nasseo was described as “inventive Arizona entrepreneurs who are creating technology solutions with potential global implications.” Nasseo is headquartered at the BioInspire Medtech incubator in Peoria, AZ which is sponsored by BioAccel who also invested $300K into the company as part of the seed round.

Nasseo’s medical innovation has resonated with audiences across industries. The company most recently won CONNECT’s Life Sciences Capital Competition earlier this year, earning it prestigious membership as a CONNECT Portfolio Company and the distinction as a “Rock Star of Innovation” by CONNECT. Prior to that, Nasseo had been invited to showcase its work at the 2012 World’s Best Technology (WBT) Innovation Marketplace and the 2013 National Innovation Showcase. And in its earliest victory, Nasseo made history at the UC San Diego (UCSD) Business Plan Competition, as the first startup to win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, “We appreciate AIC’s recognition of the urgency to commercialize our ground-breaking technology. Not only is this implant technology unique, but the implications are far-reaching. This award will offer a significant boost as we initiate production and sales of the Nasseo TiArray™ Dental Implant for patients in need.”

The company’s efforts to raise a $2M+ Series A investment round by the Fall of 2013 are also underway. Along with today’s award, the Series A funding will be used toward production and sales of the company’s TiArray™ Dental Implant to improve dental implant standards. The funding will also be used to develop a PEEK based spinal implant that integrates Nasseo’s same core implant surface modification technology.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art implant surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in Phoenix, AZ and San Diego, CA. For more information, please contact us at info(at)nasseo(dot)com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10846687.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nasseo Wins CONNECT Life Sciences Capital Competition and Joins CONNECT Portfolio
2. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
3. Neogen announces Bohannon retirement, successor named
4. SoundConnect Named Adobe Connect Channel Partner
5. Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
6. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
7. St. Jude scientist named Howard Hughes Medical Institute investigator
8. CellHealth Institute is Named 2013 Edison Award Winner
9. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
10. Street Named After EMCO High Voltage Corporation
11. Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):